Sastasundar Ventures Stock Screener | Share Price & Fundamental Analysis

SASTASUNDR Healthcare Service Provider
Screen Sastasundar Ventures share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹319.55
▲ 3.80 (1.20%)
2026-01-05 00:00:00
Share Price BSE
₹320.15
▲ 8.30 (2.66%)
2026-01-05 00:00:00
Market Cap ₹1,004.42 Cr.
P/B Ratio 1.38
EPS (TTM) ₹-28.66
Dividend Yield -
Debt to Equity -
52W High ₹328.35
52W Low ₹208.23
Operating Margin -9.00%
Profit Margin 5.84%
Revenue (TTM) ₹308.00
EBITDA ₹-3.00
Net Income ₹18.00
Total Assets ₹974.00
Total Equity ₹865.00

Sastasundar Ventures Share Price History - Stock Screener Chart

Screen SASTASUNDR historical share price movements with interactive charts. Analyze price trends and patterns.

Sastasundar Ventures Company Profile - Fundamental Screener

Screen Sastasundar Ventures company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SASTASUNDR shares.
Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E
ISIN INE019J01013

Sastasundar Ventures Balance Sheet Screener - Fundamental Analysis

Fair Value Analysis
Screen SASTASUNDR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Assets
Total Assets 974 1,150 1,206 1,278 293 316 231 236 251 256
Current Assets 267 354 575 508 131 137 66 95 108 90
Fixed Assets 102 110 107 93 110 114 116 117 125 126
Liabilities
Total Liabilities 974 1,150 1,206 1,278 293 316 231 236 251 256
Current Liabilities 5 72 102 116 3 3 8 5 7 7
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 865 1,000 994 1,094 229 246 200 203 195 218
Share Capital 32 32 32 32 32 32 32 32 32 32
Reserves & Surplus 638 726 717 790 163 173 106 144 158 186
Screen SASTASUNDR income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun 2022-Sept 2022-Dec
Revenue 308 324 307 325 299 296 270 322 348 368 395 161 197 260 285
Expenses 311 292 324 317 273 468 307 324 327 355 371 194 222 269 291
EBITDA -3 31 -17 8 26 -172 -38 -3 21 13 24 -33 -25 -8 -6
Operating Profit % -9.00% 2.00% -8.00% -3.00% -1.00% -71.00% -9.00% -4.00% 3.00% 1.00% 1.00% -24.00% -16.00% -6.00% -4.00%
Depreciation 1 1 1 3 2 2 1 3 2 2 2 1 1 2 2
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -5 30 -19 5 25 -174 -39 -6 19 11 21 -34 -26 -11 -9
Tax -22 4 -3 -17 -16 -19 -1 42 19 23 24 -8 -1 -8 18
Net Profit 18 27 -15 22 41 -155 -38 -48 0 -12 -3 -26 -25 -3 -26
EPS 4.30 7.52 -3.99 5.17 9.79 -34.40 -8.47 -10.75 0.41 -2.55 -0.23 -6.07 -6.24 -0.39 -6.00

Sastasundar Ventures Cash Flow Screener - Liquidity Fundamentals

Screen SASTASUNDR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities -17 36 -112 -207 -31 -69 -30 -49 -2 -12
Investing Activities -1 -34 133 220 21 -22 -2 15 4 -1
Financing Activities 0 -2 -2 -11 4 103 26 33 5 13
Net Cash Flow -19 0 19 1 -5 11 -6 -2 7 0
Screen SASTASUNDR shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar
Promoter Holding 74.11% 74.24% 74.24% 73.92% 73.92% 73.92% 73.94% 73.92%
FII Holding 1.60% 1.88% 2.04% 0.56% 0.61% 0.99% 1.71% 0.00%
DII Holding 2.06% 2.09% 2.07% 0.96% 1.35% 1.98% 1.85% 0.09%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 13.70% 13.35% 12.84% 16.06% 15.05% 14.47% 14.09% 15.09%
Other Holding 8.52% 8.44% 8.81% 8.51% 9.07% 8.63% 8.41% 10.90%
Shareholder Count 13,693 13,452 13,012 14,544 14,493 15,360 14,093 15,088

Sastasundar Ventures Dividend Screener - Share Yield Analysis

Screen SASTASUNDR dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
No dividends declared by Sastasundar Ventures.

Sastasundar Ventures Index Membership - Market Screener Classification

Screen SASTASUNDR by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.

Sastasundar Ventures Market Events Screener - Corporate Actions

Screen SASTASUNDR market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 13.20%
Annual General Meeting NA -0.32%
Change Of Name NA -
2025-11-13 2025-11-13 Quarterly Result Announcement NA -2.91%
2025-08-12 2025-08-12 Quarterly Result Announcement NA 2.84%
2025-05-30 2025-05-30 Quarterly Result Announcement NA -1.50%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -2.28%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -5.09%

Sastasundar Ventures Competitors Screener - Peer Comparison

Screen SASTASUNDR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 24,700 46.83 2,555 11.28% 492 51.43
Vijaya Diagnostic Centre 10,881 70.34 700 23.06% 144 61.34
Metropolis Healthcare 10,019 61.96 1,346 10.64% 146 53.04
Thyrocare Technologies 7,309 56.28 702 20.80% 91 53.15
Nephrocare Health Services 4,760 68.04 770 33.97% 67
Krsnaa Diagnostics 2,379 28.37 743 16.70% 78 46.09
Suraksha Diagnostic 1,441 45.66 256 15.11% 31 45.86
One Global Service Provider 1,237 28.65 148 134.60% 19 58.56
3B BlackBio DX 1,214 24.67 112 28.72% 48 56.43
Sastasundar Ventures 1,004 -103.51 1,171 -18.47% -134 60.55

Sastasundar Ventures Company Announcements - News Screener

Screen SASTASUNDR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-01-03 Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015 View
2025-12-29 Closure of Trading Window View
2025-12-17 Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015 View
2025-12-11 Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015 View
2025-12-08 Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015 View
2025-12-04 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-12-02 Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015 View
2025-11-29 Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015 View
2025-11-24 Announcement under Regulation 30 (LODR)-Earnings Call Transcript View
2025-11-22 Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015 View
2025-11-20 Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015 View
2025-11-19 Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015 View
2025-11-18 Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 View
2025-11-18 Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 View
2025-11-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome View
2025-11-15 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-11-13 Announcement under Regulation 30 (LODR)-Investor Presentation View
2025-11-13 Results - Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September 2025 View
2025-11-13 Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th November 2025 View
2025-11-11 Disclosure Under Reg 30 Of SEBI (LODR) Reg 2015 - Update On The Buy-Back Proposal By Sastasundar Healthbuddy Limited Unlisted Material Subsidiary Of The Company View